MIRD-237 is a report published by the Medical Internal Radiation Dose (MIRD) Committee, which provides guidance on the use of Iodine-131 (I-131) for therapeutic purposes. The report, titled "MIRD Pamphlet No. 237: Radionuclide Therapy with Iodine-131", offers comprehensive information on the dosimetry, treatment, and safety considerations for patients undergoing I-131 therapy.
: MIRD guidelines, including documents like MIRD-237 if it refers to a specific dosimetry schema or radionuclide, are used by professionals in nuclear medicine to standardize practices and ensure patient safety. MIRD-237
The Medical Internal Radiation Dose (MIRD) committee has developed a set of guidelines for radiation protection and dosimetry. MIRD-237 is a crucial document that provides standardized methods for calculating internal radiation doses. This guide aims to summarize the key points of MIRD-237 and provide practical advice for professionals working with radiation. The MIRD-237: A Comprehensive Review of its History,